Verified earnings results
Prelude Therapeutics Q2 2026 Earnings Results
Direct answer
Prelude Therapeutics reported Q2 2026 results on August 11, 2026.
Revenue was 5,704,000. EPS beat the estimate by 30.21%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Prelude Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- August 11, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- -0.2006
- Reported EPS
- -0.14
- Revenue
- 5,704,000
- EPS surprise
- EPS beat the estimate by 30.21%.
Explore related company data
Read the frequently asked questions.
When did Prelude Therapeutics report Q2 2026 earnings?
Prelude Therapeutics reported on August 11, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for Prelude Therapeutics?
The verified record provides an EPS estimate of -0.2006.
Has Prelude Therapeutics reported the Q2 2026 result?
Revenue was 5,704,000. EPS beat the estimate by 30.21%.
Which source supports this Prelude Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.